Mediators of Central Nervous System Damage During the Progression of Human T-Cell Leukemia Type I-Associated Myelopathy/Tropical Spastic Paraparesis

References

• Alefantis T, Barmak K, Harhaj E, Grant C, Wigdahl B (2003). Characterization of a nuclear export signal within the human T cell leukemia virus type I transactivator pro-tein Tax. In press.
   Google Scholar
• Ali A, Patterson S, Cruickshank K, Rudge P, Dalgleish AG, Knight SC (1993). Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and trop-ical spastic paraparesis. Gun Exp Immunol 94: 32–37.
   Google Scholar
• Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR (1998). Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478–480.
   PubMed Web of Science ®Google Scholar
• Biddison WE, Kubota R, Kawanishi T, Taub DD, Cruikshank WW, Center DM, Connor EW, Utz U, Jacobson S (1997). Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 159: 2018–2025.
   Google Scholar
• Cabre P, Smadja D, Cabie A, Newton CR (2000). HTLV-1 and HIV infections of the central nervous system in tropical areas. I Neurol Neurosurg Psychiatry 68: 550–557.
   Google Scholar
• Cavrois M, Gessain A, Gout O, Wain-Hobson S, Wattel E (2000). Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect Dis 182: 1044–1050.
   Web of Science ®Google Scholar
• Coscoy L, Gonzalez-Dunia D, Brahic M, Ozden S (1997). Infection of choroid plexus cells by human T cell leukaemia virus type I. J Gen Virol 78(Pt 1): 143–146.
   Google Scholar
• El-Sabban ME, Merhi RA, Haidar HA, Arnulf B, Khoury H, Basbous J, Nijmeh J, de The H, Hermine O, BazarbachiA (2002). Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. Blood 99: 3383–3389.
   PubMed Web of Science ®Google Scholar
• Feuer G, Fraser JK, Zack JA, Lee F, Feuer R, Chen IS (1996). Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus in-fection during differentiation in vitro and in vivo. J Virol 70: 4038–4044.
   PubMed Web of Science ®Google Scholar
• Grant C, Barmak K, Alefantis T, Yao J, Jacobson S, WigdahlB (2002). Human T cell leukemia virus type I and neuro-logic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physio1190: 133–159.
   Google Scholar
• Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP (1998). Direct vi-sualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8(±) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Nati Acad Sci US A 95: 7568–7573.
   PubMed Web of Science ®Google Scholar
• Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S (2002). Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20: 621–667.
   PubMed Web of Science ®Google Scholar
• Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR (2000a). Abundant tax protein expression in CD4+ T cells in-fected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95: 1386–1392.
   PubMed Web of Science ®Google Scholar
• Hanon E, Stinchcombe JC, Saito M, Asquith BE, Taylor GP, Tanaka Y, Weber JN, Griffiths GM, Bangham CR (2000b). Fratricide among CD8(±) T lymphocytes naturally in-fected with human T cell lymphotropic virus type I. Immunity 13: 657–664.
   PubMed Web of Science ®Google Scholar
• Harhaj EW, Good L, Xiao G, Sun SC (1999). Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene 18: 1341–1349.
   PubMed Web of Science ®Google Scholar
• Hoffman PM, Dhib-Jalbut S, Mikovits JA, Robbins DS, Wolf AL, Bergey GK, Lohrey NC, Weislow OS, Ruscetti FW (1992). Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cul-tures. Proc Nati Acad Sci US A 89: 11784–11788.
   Google Scholar
• Jacobson S, McFarlin DE, Robinson S, Voskuhl R, Martin R, Brewah A, Newell AJ, Koenig S (1992). HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of pa-tients with HTLV-I-associated neurological disease. Ann Neurol 32: 651–657.
   Google Scholar
• Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990). Circulating CD8+ cytotoxic T lymphocytes spe-cific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245–248.
   PubMed Web of Science ®Google Scholar
• Kasai T, Ikeda H, Tomaru U, Yamashita I, Ohya O, Morita K, Wakisaka A, Matsuoka E, Moritoyo T, Hashimoto K, Higuchi I, Izumo S, Osame M, Yoshiki T (1999). A rat model of human T lymphocyte virus type I (HTLV-I) in-fection: in situ detection of HTLV-I provirus DNA in mi-croglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy. Acta Neuropathol (Berl) 97: 107–112.
   Google Scholar
• Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, Sakaki Y, Goto I (1992). Antibody titers to HTLV-I-p4Otax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/ tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. I Neurol Sci 107: 98–104.
   Google Scholar
• Kubota R, Furukawa Y, Izumo S, Usuku K, Osame M (2003). Degenerate specificity of HTLV-I-specific CD8+ T cells during viral replication in patients with HTLV-I-associated myelopathy (HAM/TSP). Blood 101: 3074–3081.
   Google Scholar
• Kubota R, Soldan SS, Martin R, Jacobson S (2002). Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient. I Neu-roVirol 8: 53–57.
   Google Scholar
• Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M (1994). HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. I Neuroimmunol 53: 23–29.
   Google Scholar
• Levin MC, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, Chang G, Posner JB, Jacobson S (1998). Neu-ronal molecular mimicry in immune-mediated neuro-logic disease. Ann Neurol 44: 87–98.
   PubMed Web of Science ®Google Scholar
• Levin MC, Krichavsky M, Fox RJ, Lehky T, Jacobson S, Fox C, Kleghorn F, White J, Young N, Edwards RJ, Jack NE, Bartholomew C (1997a). Extensive latent retrovi-ral infection in bone marrow of patients with HTLV-I-associated neurologic disease. Blood 89: 346–348.
   Google Scholar
• Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC Jr, Hasty KA, Callaway JC, Zunt J, Desiderio D, Stuart JM (2002). Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 8: 509–513.
   PubMed Web of Science ®Google Scholar
• Levin MC, Lehky TJ, Flerlage AN, Katz D, Kingma DW, Jaffe ES, Heiss JD, Patronas N, McFarland HF, Jacobson S (1997b). Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lym-photropic virus type I-associated neurologic disease. N Engl I Med 336: 839–845.
   PubMedGoogle Scholar
• Mahana W, Samaan A, Zhao TM, Kindt TJ, Simpson RM (2000). Evidence for humoral and cellular reactivity against keratin and thyroglobulin in HTLV-I infected rab-bits. Autoimmunity 32: 57–65.
   PubMed Web of Science ®Google Scholar
• Makino M, Shimokubo S, Wakamatsu SI, Izumo S, Baba M (1999). The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic para-paresis. J Virol 73: 4575–4581.
   Google Scholar
• Makino M, Utsunomiya A, Maeda Y, Shimokubo S, Izumo S, Baba M (2001). Association of CD40 ligand expression on HTLV-I-infected T cells and maturation of dendritic cells. Scand I Immunol 54: 574–581.
   Google Scholar
• Makino M, Wakamatsu S, Shimokubo S, Arima N, Baba M (2000). Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia. Virology 274: 140–148.
   Google Scholar
• Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S (2001). CD8(±) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98: 1858–1861.
   PubMed Web of Science ®Google Scholar
• Parker CE, Daenke S, Nightingale S, Bangham CR (1992). Activated, HTLV-1-specific cytotoxic T-lymphocytes arefound in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 188: 628–636.
   PubMed Web of Science ®Google Scholar
• Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG (1990). In vivo cellular tropism of hu-man T-cell leukemia virus type 1. J Virol 64: 5682–5687.
   PubMed Web of Science ®Google Scholar
• Ridge JP, Di Rosa F, Matzinger P (1998). A conditioned den-dritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393: 474–478.
   PubMed Web of Science ®Google Scholar
• Schoenberger SP, Toes RE, van der Voort El, Offringa R, Melief CJ (1998). T-cell help for cytotoxic T lymphocytes is mediated by CD4O-CD4OL interactions. Nature 393: 480–483.
   PubMed Web of Science ®Google Scholar
• Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF (1991). Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 147: 1522–1529.
   Google Scholar
• Szymocha R, Akaoka H, Brisson C, Beurton-Marduel P, Chalon A, Bernard A, Didier-Bazes M, Belin MF, Giraudon P (2000a). Astrocytic alterations induced by HTLV type 1-infected T lymphocytes: a role for Tax-1 and tumor necrosis factor alpha. AIDS Res Hum Retroviruses 16: 1723–1729.
   Google Scholar
• Szymocha R, Brisson C, Bernard A, Akaoka H, Belin MF, Giraudon P (2000b). Long-term effects of HTLV-1 on brain astrocytes: sustained expression of Tax-1 asso-ciated with synthesis of inflammatory mediators. J NeuroVirol 6: 350–357.
   Web of Science ®Google Scholar
• Tendler CL, Greenberg SJ, Burton JD, Danielpour D, Kim SJ, Blattner WA, Maims A, Waldmann TA (1991). Cy-tokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 46: 302–311.
   PubMedGoogle Scholar
• Umehara F, Izumo S, Takeya M, Takahashi K, Sato E, Osame M (1996). Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol (Berl) 91: 343–350.
   Google Scholar
• Watabe K, Saida T, Kim SU (1989). Human and simian glial cells infected by human T-lymphotropic virus type I in culture. J Neuropathol Exp Neurol 48: 610–619.
   Google Scholar
• Watanabe H, Nakamura T, Nagasato K, Shirabe S, Ohishi K, Ichinose K, Nishiura Y, Chiyoda S, Tsujihata M, Nagataki S (1995). Exaggerated messenger RNA expression of in-flammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy. Arch Neurol 52: 276–280.
   Google Scholar
• Yamada M, Watabe K, Saida T, Kim SU (1991). Increased susceptibility of human fetal astrocytes to human T-lymphotropic virus type I in culture. J Neuropathol Exp Neurol 50: 97–107.
   Google Scholar
• Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, Tomaru U, Takenouchi N, Izumo S, Osame M, Jacobson S (2002). Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(±) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99: 88–94.
   PubMed Web of Science ®Google Scholar